Amesite to Present at Sidoti Virtual Investor Conference January 22-23 on AI-Powered App, NurseMagic™
Amesite Inc. (NASDAQ: AMST) announced its participation in the Sidoti January Virtual Investor Conference on January 22-23, 2025, where CEO Dr. Ann Marie Sastry and VP of Sales Brandon Owens will present the company's success with NurseMagic™. The presentation is scheduled for January 22 at 10:45am ET.
NurseMagic™, the company's AI-driven healthcare solution, has achieved significant market penetration since its recent launch, now serving users across 87 different healthcare professions in all 50 US states and 21 countries. The platform supports various healthcare professionals, from registered nurses to healthcare CEOs, and has secured enterprise sales with major home care franchise companies. The solution includes both consumer subscriptions and a HIPAA-compliant enterprise offering.
Amesite Inc. (NASDAQ: AMST) ha annunciato la sua partecipazione alla Sidoti January Virtual Investor Conference che si terrà il 22-23 gennaio 2025, dove l'amministratore delegato Dr. Ann Marie Sastry e il vicepresidente delle vendite Brandon Owens presenteranno i successi dell'azienda con NurseMagic™. La presentazione è programmata per il 22 gennaio alle 10:45 ET.
NurseMagic™, la soluzione healthcare basata sull'IA dell'azienda, ha raggiunto una significativa penetrazione di mercato dal suo recente lancio, servendo ora utenti in 87 professioni sanitarie diverse in tutti i 50 stati degli Stati Uniti e in 21 paesi. La piattaforma supporta vari professionisti della salute, dagli infermieri registrati ai CEO nel settore sanitario, e ha ottenuto vendite aziendali con importanti aziende di franchising per l'assistenza domiciliare. La soluzione comprende sia abbonamenti per i consumatori che un'offerta enterprise conforme a HIPAA.
Amesite Inc. (NASDAQ: AMST) anunció su participación en la Sidoti January Virtual Investor Conference que tendrá lugar el 22-23 de enero de 2025, donde la CEO Dra. Ann Marie Sastry y el VP de Ventas Brandon Owens presentarán el éxito de la empresa con NurseMagic™. La presentación está programada para el 22 de enero a las 10:45 am ET.
NurseMagic™, la solución de atención médica impulsada por IA de la empresa, ha logrado una penetración significativa en el mercado desde su reciente lanzamiento, ahora sirviendo a usuarios en 87 diferentes profesiones de salud en los 50 estados de EE. UU. y 21 países. La plataforma apoya a varios profesionales de la salud, desde enfermeras registradas hasta CEO de atención médica, y ha asegurado ventas empresariales con grandes empresas de franquicia de atención domiciliaria. La solución incluye tanto suscripciones para consumidores como una oferta empresarial compatible con HIPAA.
Amesite Inc. (NASDAQ: AMST)는 2025년 1월 22일부터 23일까지 열리는 Sidoti January Virtual Investor Conference에 참여한다고 발표했습니다. 이 자리에서 CEO Dr. Ann Marie Sastry와 영업부 VP Brandon Owens이 NurseMagic™에 대한 회사의 성공을 발표할 예정입니다. 발표는 1월 22일 오전 10시 45분 ET로 예정되어 있습니다.
NurseMagic™은 회사의 AI 기반 의료 솔루션으로 최근 출시 이후 시장에서 꽤 큰 점유율을 차지하게 되었으며, 현재 미국 50개 주와 21개국의 87개 다양한 의료 전문직에서 사용자들에게 서비스를 제공합니다. 이 플랫폼은 등록 간호사에서부터 의료 CEO에 이르기까지 다양한 의료 전문가를 지원하며, 주요 홈케어 프랜차이즈 회사들과의 기업 판매를 확보했습니다. 이 솔루션은 소비자 구독과 HIPAA 준수 기업 제공을 모두 포함합니다.
Amesite Inc. (NASDAQ: AMST) a annoncé sa participation à la Sidoti January Virtual Investor Conference qui se tiendra les 22 et 23 janvier 2025, où la PDG Dr. Ann Marie Sastry et le VP des Ventes Brandon Owens présenteront le succès de l'entreprise avec NurseMagic™. La présentation est prévue pour le 22 janvier à 10h45 ET.
NurseMagic™, la solution de santé basée sur l'IA de l'entreprise, a connu une pénétration significative du marché depuis son récent lancement, servant désormais des utilisateurs dans 87 professions de santé différentes dans les 50 États américains et 21 pays. La plateforme soutient divers professionnels de la santé, des infirmières autorisées aux PDG de soins de santé, et a sécurisé des ventes d'entreprise avec de grandes entreprises de franchise de soins à domicile. La solution inclut des abonnements pour les consommateurs ainsi qu'une offre d'entreprise conforme aux normes HIPAA.
Amesite Inc. (NASDAQ: AMST) hat seine Teilnahme an der Sidoti January Virtual Investor Conference angekündigt, die am 22. und 23. Januar 2025 stattfinden wird. Dort werden CEO Dr. Ann Marie Sastry und VP Sales Brandon Owens den Erfolg des Unternehmens mit NurseMagic™ präsentieren. Die Präsentation ist für den 22. Januar um 10:45 Uhr ET geplant.
NurseMagic™, die KI-gesteuerte Gesundheitslösungen des Unternehmens, hat seit ihrer kürzlichen Einführung eine signifikante Marktpenetration erreicht und bedient nun Nutzer in 87 verschiedenen Gesundheitsberufen in allen 50 US-Staaten und 21 Ländern. Die Plattform unterstützt verschiedene Gesundheitsfachkräfte, von registrierten Krankenschwestern bis hin zu CEOs im Gesundheitswesen, und hat Unternehmenskunden bei großen Franchiseunternehmen im Bereich der häuslichen Pflege gewonnen. Die Lösung umfasst sowohl Verbrauchersubscriptionen als auch ein HIPAA-konformes Unternehmensangebot.
- Rapid market expansion across 50 states and 21 countries
- Successful enterprise sales to major home care franchise companies
- Platform adoption across 87 different healthcare professions
- HIPAA compliance achievement enabling enterprise sales
- None.
Company to Discuss Growth for NurseMagic™ for both B2C and B2B Users in 50 States and 21 Countries, Representing 87 Professions
DETROIT, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading technology company specializing in AI-driven solutions for B2C and B2B markets, announced today that CEO Dr. Ann Marie Sastry will present and host one-on-one meetings with investors at the Sidoti January Virtual Investor Conference on January 22-23, 2025. Joining her in presenting Amesite’s recent success in the NurseMagicTM market launch will be Mr. Brandon Owens, VP of Sales.
The presentation will begin at 10:45am ET on Wednesday, January 22, 2025, and can be accessed live, via a link – to be provided on Amesite’s website, and announced on its social media channels. Amesite will also host virtual one-on-ones with investors on Wednesday and Thursday, January 22-23, 2025. To register for the presentation or one-on-ones, visit www.sidoti.com/events. Registration and access are free and participants are not required to be Sidoti clients.
NurseMagic™ has seen strong user growth since its launch a few months ago and now supports users from eighty-seven (87) professions (ranging from registered nurses, to physicians, EMTs, occupational therapists, hospital managers, healthcare CEOs and dozens more) in all fifty (50) states and twenty-one (21) countries. Availability of a consumer subscription followed the successful launch of NurseMagic™’s enterprise offering, which meets HIPAA regulatory requirements. Amesite recently announced enterprise sales in high growth companies with hundreds of franchisees.
“We are excited to provide details on the sales opportunities and motions for NurseMagicTM to our investors,” said Brandon Owens, VP of Sales of Amesite. “The incredibly positive response to NurseMagicTM, including enterprise sales to franchisees of some of the largest home care providers in the country, gives us confidence that the solution will scale rapidly.”
“Our presentation will include discussions on sustainable revenue growth with NurseMagicTM, because of its creation of dramatically improved efficiency in healthcare, as a first-in-space solution for some of the largest groups of health and home care providers in the nation,” said Amesite CEO Dr. Ann Marie Sastry. “We are excited to talk with investors, whom we believe will recognize the substantial opportunity for growth of our AI-powered NurseMagicTM solution.”
About Amesite Inc.
Amesite Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, including its higher ed platform that offers professional learning. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic™, the company’s mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.
Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact
MJ Clyburn
TraDigital IR
clyburn@tradigitalir.com
FAQ
What is the current market reach of Amesite's NurseMagic™ platform (AMST)?
When is Amesite (AMST) presenting at the Sidoti Virtual Investor Conference?
What types of healthcare professionals use Amesite's NurseMagic™ platform (AMST)?